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ARTICLE
Chemodivergent manganese-catalyzed C–H
activation: modular synthesis of fluorogenic probes
Nikolaos Kaplaneris1,4, Jongwoo Son1,4, Lorena Mendive-Tapia2,4, Adelina Kopp1, Nicole D. Barth2,
Isaac Maksso1, Marc Vendrell 2✉ & Lutz Ackermann 1,3✉
Bioorthogonal late-stage diversification of amino acids and peptides bears enormous
potential for drug discovery and molecular imaging. Despite major accomplishments, these
strategies largely rely on traditional, lengthy prefunctionalization methods, heavily involving
precious transition-metal catalysis. Herein, we report on a resource-economical manganese
(I)-catalyzed C–H fluorescent labeling of structurally complex peptides ensured by direct
alkynylation and alkenylation manifolds. This modular strategy sets the stage for unraveling
structure-activity relationships between structurally discrete fluorophores towards the
rational design of BODIPY fluorogenic probes for real-time analysis of immune cell function.
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The fluidity of cell membranes is an essential micro-environmental feature associated with many biologicalprocesses, including the transport of biomolecules, activity
of membrane-bound proteins, protein–protein interactions, and
metabolic reactions1. It is not surprising, therefore, that the
dysregulation of membrane fluidity has been linked to cellular
abnormalities in a variety of diseases2,3. In this regard, imaging
studies to reveal how the composition of cell membranes changes
in real-time are of key importance, both in biomedical studies as
well as in the translation of new therapeutics. Fluorogenic
molecular rotors have been recognized as attractive tools for
sensing changes in the viscosity and polarity of live cells4. In the
past few years, environmentally-sensitive fluorophores have been
developed to image in vivo cell-specific events associated with
infection, inflammation, and cancer5–10. However, this approach
largely involves elements of substrate prefunctionalization. As a
consequence, new approaches for late-stage fluorogenic labeling
of biomolecules are required to assemble molecular probes that
enable real-time imaging of membrane fluidity as direct reporters
of cell function. The position- and chemo-selective modification
of biologically relevant compounds is in high demand to program
late-stage diversification of biomolecules with new spectral and
biological capabilities11–13. This linch-pin approach allows to
stitch different chemical moieties together to access highly
functional entities with unique properties14. A major challenge in
peptide functionalization is represented by the need for pre-
dictable, robust, and mild methods. Until recently, the mod-
ification of amino acids and peptides has largely relied on classical
condensations, (cyclo)additions, or metal-catalyzed cross-cou-
plings with two prefunctionalized substrates15–18. During the last
decade, C–H activation has become an increasingly viable tool for
molecular syntheses19–23. Enormous efforts have been devoted to
establishing C–H functionalizations of amino acids with the toxic
4d transition metals palladium and ruthenium24–29, whilst Earth-
Fig. 1 Divergent and modular assembly of fluorogenic probes via Earth-abundant manganese(I)-catalyzed C–H activation. a A versatile approach
towards diverse fluorogenic probes. b Selected optimization findings for the utilization of bromoalkyne B1 and terminal alkyne B2 to furnish linear
alkynylated and bent alkenylated BODIPY amino acid imaging probes. 2-py, 2-pyridyl; SAR, structure–activity relationship; (1-Ad)CO2H, 1-
adamantanecarboxylic acid; DCE, 1,2-dichloroethane; PivOH, pivalic acid.
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abundant 3d transition metal catalysis continues to be scarce30–33.
Manganese complexes typically demonstrate low toxicity, thus its
utilization in C–H functionalization is highly desirable. While the
viability of manganese(I)-catalysis for C–H activation has been
documented34–37, late-stage diversifications of structurally com-
plex peptides towards molecular imaging have thus far unfortu-
nately proven elusive. CD8+ T cells are an effector subset of
lymphocytes that represent the main line of defense of the
adaptative immune system against infections and cancer38–40.
Importantly, recent studies showed evidence that the composition
of the plasma membrane of CD8+ T cells is directly related to
their cytotoxic capability41,42. Since the biological activity of
T cells can be indicative of how the host immune system is
responding to disease, we focussed our design on the construction
of functional BODIPY reporters of CD8+ T cell function.
Thus, we devise a manganese-catalyzed linch-pin strategy to
stitch peptides with BODIPY fluorophores featuring excellent
photophysical properties. Notably, the nature of the molecular
linkage is identified as a key design element to modulate the
fluorescent properties. This approach sets the stage for facilitating
structure-activity relationship studies of BODIPY fluorogenic
probes as well as the construction of unique functional reporters
of cell activity. Herein, we exploit the environmentally-sensitive
fluorogenicity of BODIPY chemotypes to image changes in the
composition of the cell membrane of CD8+ T cells as direct
indicators of their functional state.
Fig. 2 Manganese-catalyzed fluorescent labeling of small peptides via late-stage C–H stitching. Synthesis of peptides 6–18 featuring a linear linker
between the BODIPY fluorophore and the tryptophan amino acid via C–H alkynylation.
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Results and discussion
Our strategy for a divergent assembly point for the preparation of
fluorescent peptides with tunable optical properties identified
internal bromoalkynes35 and terminal alkynes36 as the substrates.
We envisioned that, by employing these architectures, we could
gain access to fluorescent imaging probes, in which the phenyl-
BODIPY fluorescent core would be stitched to the indole-moiety
of the tryptophan amino acid via a linear alkynyl or a bent alkenyl
spacer, while at the same time extending the conjugate π-system
to fine-tune the fluorogenic behavior. We envisioned that this
linkage would not only alter the fluorescent properties of the
peptide but also render fluorescent molecular rotors (Fig. 1a). To
reduce our hypothesis into practice, we exploited an insertion/β-
elimination manifold, via the combination of KOAc and BPh3,
that enabled, under exceedingly mild, racemization-free reaction
conditions, efficient alkynylation to selectively deliver BODIPY-
labeled amino acid 2 with a linear linkage (Fig. 1b and Supple-
mentary Tables 1 and 2). The beneficial assets of the Lewis-acidic
BPh3 are attributed to ensuring an efficient β-bromide
elimination35. In sharp contrast, (1-Ad)CO2H as additive facili-
tated an insertion/protodemetalation manifold with terminal
BODIPY-alkyne B2, providing the bent spacer (Fig. 1b). The acid
additive is proposed to enable efficient carboxylate-assisted C–H
activation while accelerating the protodemetalation43–45.
With the optimal reaction conditions for late-stage fluorescent-
labeling in hand, we explored the generality of our alkynylation
regime in a broad range of small peptides (Fig. 2). Gratifyingly,
the reaction conditions tolerated various tryptophan derivatives,
delivering the desired fluorogenic amino acid derivatives 2, 6, and
7 with remarkable efficacy. Moreover, our approach proved viable
to BODIPY-alkyne B3 decorated with aryl groups at the alpha
pyrrole positions to bathochromically shift the emission
Fig. 3 Manganese-catalyzed fluorescent labeling of small peptides via late-stage C–H stitching. Synthesis of peptides 20–45 featuring a bent linker
between the BODIPY fluorophore and the tryptophan amino acid via late-stage C–H alkenylation.
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wavelength of the thus-obtained amino acid 9. The robustness of
our strategy is asserted with the preparation of various dipeptides
which were selectively labeled without epimerization.
Encouraged by the versatility of the manganese(I)-catalysis, we
next investigated the late-stage diversification of complex pep-
tides under the alkenylation manifold (Fig. 3). In this regard,
various terminal BODIPY-alkynes (B) bearing substituents on the
fluorescent core were efficiently converted to the desired labelled
amino acid derivatives 3, and 20–25 with complete E-selectivity.
Importantly, the manganese(I)-catalyzed C–H activation even
occurred at physiological temperature of 37 °C. Furthermore, the
reaction time could be significantly reduced to only 100 min,
when using a flow setup connected to a cartridge filled with the
metal scavenger, QuadraPure™ IDA. Thereby, the residual
manganese level was reduced to 6.1 ppm, as determined by
inductively coupled plasma mass spectrometry (ICP-MS) analy-
sis. Likewise, we provided access to the free fluorescent amino
acid 22 as a building block for the synthesis of larger fluorogenic
peptides. Various di- and tripeptides with unprotected, -OH,
-CO2H, and -NH2-free amino acids, such as tryptophan, tyrosine,
serine, threonine, and lysine, were converted in a site- and che-
moselective fashion. Also, fluorescent free-C-terminus dipeptide
34 was obtained in a positional selective fashion. Triggered by the
robustness of our alkenylation regime, we examined whether
more complex peptides would be amenable to this site-selective
labeling process. To this end, tripeptides 4 were site-, chemo-, and
diastereo-E-selectively converted. The robustness of our alkeny-
lation regime was demonstrated by the efficient synthesis of the
Fig. 4 Manganese-catalyzed fluorescent labeling of complex peptides via late-stage C–H stitching. Synthesis of peptides 47–53 featuring a bent linker
between the BODIPY fluorophore and the tryptophan via C–H stitching, late-stage diversification of natural product derivatives featuring the 2,5-
diketopiperazine core (54–57) and synthesis of fluorescent cyclic peptides via C–H alkenylation.
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fluorescent dipeptide 28 and tripeptide 38 at 60 °C. Tryptophan
derivatives containing lipophilic tails at the N-terminus where
also subjected to the labeling process to afford modulated lipo-
philic rotors that could be used as membrane fluidity probes (vide
infra). Thus, the linch-pin approach stitched lauric, palmitic,
stearic, and cis-oleic acid together onto tryptophans, leading to E-
bent fluorogenic probes 41–44. Moreover, the traceless removal
of the N-pyridyl group was accomplished by a selective methy-
lation/ hydrogenation protocol giving rise to NH-free trypto-
phan-containing fluorogenic amino acid 45.
Inspired by the remarkable versatility of our manganese(I)-
catalyzed alkenylation, we became attracted to manganese(I)
catalysis for the labeling of more challenging peptidic structures.
To our delight, the linch-pin approach proved robust for the
selective and efficient labeling of tetra- and pentapeptides 47–53,
featuring sensitive cystine and unprotected tryptophan and OH-
free serine (Fig. 4). Likewise, the late-stage diversification of
conformationally rigid cyclic peptides was realized, enabling
access to brevianamide F (cyclo[Trppy-Pro]) and fellutanine A
(cyclo[Trppy-Trp]) diketopiperazine fluorescent analogs 54–57
(Fig. 4). Cyclic pentapeptides were also selectively labeled, giving
access to fluorescent peptides 58 and 59 with potentially
improved resistance to proteolytic degradation (Fig. 4). These
findings assert the utility of our manganese(I) catalysis to directly
access proteolytically-stable fluorescent peptides for bioimaging
studies, without relying on lengthy de novo syntheses based on
pre-functionalized building blocks.
CD8+ T cells are key mediators of the immune response
against pathogens and cancer cells. Once T cells are activated,
they exert their killing activity through the production and release
of cytotoxic cytokines and enzymes. Within the last decades,
immunotherapies have emerged as an effective treatment to
invigorate the activity of CD8+ T cells against tumors46. How-
ever, immunotherapies show limited success and high variability
between patients, which highlights the need for chemical tools
that can provide direct readouts of immune response to accelerate
the design of more efficient treatments47. The cytotoxic ability of
CD8+ T cells has been recently linked to lipid metabolism41,42.
Different studies report that increases of cholesterol—an essential
component of lipid bilayer fluidity—in the plasma membrane are
directly associated with rapid cell proliferation and enhanced
effector function. Given the suitability of our synthetic platform
for the rapid optimization of fluorophores, we decided to explore
whether BODIPY fluorogenic probes would monitor changes in
the membrane fluidity of CD8+ T cells and behave as fluorescent
reporters of cellular activity.
First, we examined the Trp(BODIPY) analogs 2, 3, and 60 as
membrane viscosity sensors (Fig. 5a). All three analogs exhibited
similar excitation (~501 nm) and green emission (~515 nm)
maxima wavelengths (Supplementary Figs. 4–6). To examine
their response to changes in fluidity, we first measured their
fluorescence emission in water-glycerol mixtures, where the
derivative 3, including a π-conjugated double bond bridge that
could favor the charge transfer between the indole and phenyl-
Fig. 5 Evaluation of fluidity-sensitive fluorogenic BODIPY probes. a Spectral properties of the BODIPY amino acids 2, 3, and 60. λexc: 450 nm. [†]
Measured in EtOH, [‡] measured in glycerol:H2O (6:4) with fluorescein in basic EtOH as a standard, [§] measured in glycerol:H2O mixtures with increasing
viscosity. b Fluorescence bar plots displaying the fluorescence fold increase in 0–60% glycerol in water (left) and fluorescence emission in 60% glycerol-
water (right) of amino acids 2, 3, and 60 (25 µM), λexc: 450 nm. Inset) Pictograms of compound 3 under UV excitation in PBS (left) and in liposome
suspensions (right). c Fluorescence emission bar plot of lipid-fluorophore conjugates 41–44 (1 µM) after incubation in phosphatidylcholine (PC):
cholesterol liposome suspensions (gray) and in PBS (white), λexc: 450 nm. d Fluorescence confocal microscopy images of compound 41 (1 µM, green) after
incubation with DMPC-based liposomes containing increasing amounts of cholesterol. Scale bar: 10 µm. In all panels, data presented as means ± SEM from
experiments performed at least in triplicate. Fluorescence spectra of compound 41 (1 µM) in cholesterol-containing liposomes (green) and in PBS (black).
Data presented as means ± SEM (n= 4) for emission in presence of liposomes and (n= 12) for emission in PBS. P values obtained from ONE-ANOVA tests
with multiple comparisons. ε, molar extinction coefficient; lipos., liposomes; chol., cholesterol.
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BODIPY groups, showed the best fluorogenic character among all
the derivatives (Fig. 5b). The weakest response was observed for
derivative 2, which features a triple bond linkage that could lead
to increased system rigidification and a reduction of intramole-
cular charge transfer. We quantified the viscosity sensitivity
coefficients for all compounds and observed that compound 3
displayed values around 0.7, being among the most sensitive
fluorescent rotors reported to date48,49. Next, to facilitate the
anchoring of the BODIPY reporter to the plasma membrane of
live cells, we conjugated compound 3 to fatty acids of different
lengths and saturation degrees (Fig. 5c). We examined their
fluorescence emission in liposomes containing phosphatidylcho-
line and cholesterol, mimicking the cell membrane micro-
environments. Interestingly, the lauric acid derivative 41, which
had the shortest fatty acid chain (i.e., 12 carbon atoms) exhibited
the strongest fluorogenic behavior with over 80-fold increase in
emission (Fig. 5c). In view of these results, we performed confocal
microscopy experiments to compare the staining of compound 41
in liposomes containing different amounts of cholesterol. As
shown in Fig. 5d, compound 41 exhibited turn-on fluorescence
emission in response to the cholesterol content.
Encouraged by the sensitivity of compound 41 to monitor
changes in membrane fluidity, we next evaluated its utility as a
fluorescent probe for identifying small molecule drugs that acti-
vate T cells and regulate the cholesterol content in their mem-
branes. We employed a flow cytometry platform to screen a
collection of commercially available regulators of lipid metabo-
lism (Fig. 6a). Jurkat T cells were cultured using a cell pro-
liferation cocktail (i.e., anti-CD3, anti-CD28, and IL-2) and
treated with drugs or vehicle for 12 h before imaging with probe
41. Among all drugs tested, cells treated with the Acyl-CoA:
cholesterol acyltransferase inhibitor avasimibe showed the highest
fluorescence emission (Fig. 6b). Notably, avasimibe has been
reported in combination with anti-PD1 immunotherapies for the
treatment of cancer. We also examined whether compound 41
was able to detect changes in the activity of CD8+ T cells that
Fig. 6 Probe 41 enables fluorescence-based screening of small molecule modulators of CD8+ T cells. a Schematic illustration of our fluorescence-based
screening to detect cholesterol fluctuations in T cells using compound 41. b Quantification of the fluorescence emission of Jurkat T cells after incubation
with different small molecules and staining with compound 41 (1 µM, λexc/em: 488/525 nm). Data presented as means+ SEM (n= 6). c Fluorescence
confocal microscopy images of activated CD8+ T cells with avasimibe (30 µM) or without avasimibe. Cells were stained with compound 41 (1 µM, green)
and Hoechst 33342 (blue, 7 µM) (λexc/em: 405/450 nm (Hoechst), 488/525 nm (4)). White arrows point at the plasma membrane localization of probe
41. Scale bar: 10 µm. d Quantification of the fluorescence intensity (n= 7) and the percentage (n= 6) of 41-stained CD8+ T cells under different activation
conditions. Flow cytometry analysis of the CD8+ T cells markers PD-1 (no avasimibe: n= 6, IL-2 activation: n= 7, IL-2 activation+ avasimibe: n= 5) and
CD62L (no avasimibe/IL2-activation: n= 6, IL-2 activation+avasimibe: n= 9) before and after treatment with avasimibe (30 µM). In all panels, data
presented as means ± SEM from experiments performed at least in triplicate. P values obtained from unpaired two-tailed t tests.
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were freshly isolated from human peripheral blood. Fluorescence
microscopy images of compound 41 in human CD8+ T cells
exhibited bright staining of the cell membrane in avasimibe-
treated cells but not in untreated CD8+ T cells (Fig. 6c). More-
over, we performed a detailed live-cell analysis by flow cytometry
to observe that the fluorescence signal of compound 41 was
significantly higher in avasimibe-treated activated CD8+ T cells
than in naïve CD8+ T cells (Fig. 6d and Supplementary Fig. 8).
Finally, we confirmed the functional state of CD8+ T cells by
measuring the expression of receptor markers that are directly
associated with T cell activity and assessed the response of human
CD8+ T cells using antibody-based readouts (Supplementary
Fig. 7). Specifically, avasimibe-treated cells showed a slight
increase in the levels of PD-1 and a significant decrease in the
levels CD62L, which are both indicative of CD8+ T cell activation
state (Fig. 6d and Supplementary Fig. 9). Altogether, these results
highlight the utility of compound 41 as a simple and cost-effective
turn-on probe to detect subtle changes in the cholesterol content
and activation state of live human CD8+ T cells under physio-
logical conditions.
In summary, we have developed a modular linch-pin strategy
for the stereo-divergent manganese(I)-catalyzed C–H labeling of
structurally complex peptides with BODIPY probes. The modular
and robust nature of our approach sets the stage for expedient
structure–activity relationship studies of fluorogenic peptides. We
validated the Earth-abundant manganese(I) catalysis by providing
access to highly sensitive molecular rotors with the ability to sense
changes in the composition of immune cell membranes. We
identified a fluidity-sensitive probe, which emits bright fluores-
cence in response to cholesterol found in cell membranes, and
utilized it to establish a rapid fluorescence-based screening plat-
form for the identification of small molecule modulators of CD8+
T cells. Overall, our modular and divergent C–H activation
strategy will establish expedient avenues in the development of
activatable fluorophores to image cell function in real-time and
physiological conditions.
Methods
General procedure A: manganese-catalyzed C–H alkynylation of peptides. A
suspension of peptide 4 (0.10 mmol, 1.00 equiv), BODIPY-bromoalkyne B (0.11
mmol, 1.1 equiv), MnBr(CO)5 (2.7 mg, 10 mol %), KOAc (19.6 mg, 2.0 equiv), and
BPh3 (50 µL, 0.01 M in 1,4-dioxane, 0.5 mol %) in 1,4-dioxane (1.0 mL) was stirred
at 90 °C for 24 h. After cooling to ambient temperature, CH2Cl2 (10 mL) was added
and the mixture was concentrated in vacuo. Purification by column chromato-
graphy on silica gel afforded the desired products.
General procedure B: manganese-catalyzed C–H hydroarylation of peptides. A
suspension of peptide 4 (0.10 mmol, 1.0 equiv), BODIPY-alkyne B (0.11-0.20
mmol, 1.1 -2.0 equiv), MnBr(CO)5 (5.5 mg, 20 mol %), and (1-Ad)CO2H (7.2 mg,
40 mol %) in 1,4-dioxane (1.0 mL) was stirred at 100 °C for 24 h. After cooling to
ambient temperature, CH2Cl2 (10 mL) was added and the mixture was con-
centrated in vacuo. Purification by column chromatography on silica gel afforded
the desired products.
Flow cytometry analysis. Dyes were reconstituted at 10 mM in DMSO. 105 cells
were stained with compound 41 (1 μM) in HEPES-NaCl containing 0.1% BSA for
1 h at r.t. prior to staining with antibodies. Cells were washed with HEPES-NaCl
followed by staining with antihuman PD-1-PE (1:100, 10 μg mL−1), antihuman
CD62L-PE/Cy7 (1:200, 10 μg mL−1), antihuman CD39-APC (1:200, 5 μg mL−1),
and antihuman CD8-PerCP/Cy5.5 (1:200, 0.4 μg mL−1) in HEPES-NaCl contain-
ing 0.1% BSA and 1% FcR block for 20 min on ice. Cells were washed at 300 g,
5 min in HEPES-NaCl prior to staining with 25 nM Annexin V-PB in HEPES-NaCl
containing 0.1% BSA and 2 mM CaCl2. Fluorescence emission was measured on a
5 L LSR flow cytometer. Excitation sources/emission filters used: Annexin V-PB
(355 nm, 450/50 nm), 41 (488 nm, 510/20 nm), PD1-PE (561 nm, 582/15 nm),
CD62L-PE/Cy7 (561 nm, 780/60 nm), CD8-PerCP/Cy5.5 (488 nm, 710/50 nm),
CD39-APC (647 nm, 670/14 nm).
Fluorescence confocal microscopy. Confocal imaging was performed in a TCS
Leica SP8 confocal laser scanning microscope. Prior to imaging, cells were stained
with compound 41 (1 μM) for 1 h at r.t. in HEPES-NaCl containing 0.1% BSA.
Cells were further counterstained with the nuclear counterstain Hoechst 33342
(3 μM) for 10 min at r.t. Excitation/emission wavelengths: Hoechst 33342 (355 nm,
450/50 nm), 41 (488 nm, 520/40 nm). Images were processed with ImageJ.
Statistics and reproducibility. Statistical differences were analyzed two-sided
unpaired t tests using Graphpad software. Independent experiments were per-
formed at least three times, unless otherwise mentioned.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
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